Similar articles for PMID: 32601253

Year	Number of Results
2014	1
2020	109
2021	3
2023	1
2024	0

1

Further developments in the literature on RAAS inhibitors and COVID-19.

Quinn KL, Fralick M, Zipursky JS, Stall NM. Quinn KL, et al. CMAJ. 2020 Jun 29;192(26):E727. doi: 10.1503/cmaj.76076. CMAJ. 2020. PMID: 32601253 Free PMC article. No abstract available.

2

Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?

Sommerstein R, Kochen MM, Messerli FH, Gräni C. Sommerstein R, et al. J Am Heart Assoc. 2020 Apr 7;9(7):e016509. doi: 10.1161/JAHA.120.016509. Epub 2020 Apr 1. J Am Heart Assoc. 2020. PMID: 32233753 Free PMC article. No abstract available.

3

Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.

Guo X, Zhu Y, Hong Y. Guo X, et al. Hypertension. 2020 Aug;76(2):e13-e14. doi: 10.1161/HYPERTENSIONAHA.120.15572. Epub 2020 May 27. Hypertension. 2020. PMID: 32458694 Free article. No abstract available.

4

Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implications.

Hrenak J, Zorad S, Simko F. Hrenak J, et al. Gen Physiol Biophys. 2020 May;39(3):203-204. doi: 10.4149/gpb_2020019. Gen Physiol Biophys. 2020. PMID: 32525813

5

Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19.

Furuhashi M, Moniwa N, Takizawa H, Ura N, Shimamoto K. Furuhashi M, et al. Hypertens Res. 2020 Aug;43(8):837-840. doi: 10.1038/s41440-020-0478-1. Epub 2020 May 20. Hypertens Res. 2020. PMID: 32433641 Free PMC article. No abstract available.

6

A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19.

Usman MS, Siddiqi TJ, Khan MS, Ahmed A, Ali SS, Michos ED, Hall ME, Krasuski RA, Greene SJ, Butler J, Alkhouli M. Usman MS, et al. Am J Cardiol. 2020 Sep 1;130:159-161. doi: 10.1016/j.amjcard.2020.05.038. Epub 2020 Jun 2. Am J Cardiol. 2020. PMID: 32624189 Free PMC article. No abstract available.

7

[Scientific statement on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19].

Chinese Society of Cardiology of Chinese Medical Association; Editorial Board of Chinese Journal of Cardiology. Chinese Society of Cardiology of Chinese Medical Association, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jul 24;48(7):565-566. doi: 10.3760/cma.j.cn112148-20200329-00262. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32842268 Chinese.

8

COVID-19: A Concern for Cardiovascular Disease Patients.

Sharma S. Sharma S. Cardiovasc Toxicol. 2020 Oct;20(5):443-447. doi: 10.1007/s12012-020-09596-0. Epub 2020 Jul 29. Cardiovasc Toxicol. 2020. PMID: 32729064 Free PMC article. Review.

9

Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint.

Cappuccio FP, Siani A. Cappuccio FP, et al. Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1227-1235. doi: 10.1016/j.numecd.2020.05.013. Epub 2020 May 29. Nutr Metab Cardiovasc Dis. 2020. PMID: 32595085 Free PMC article.

10

What solid organ transplant healthcare providers should know about renin-angiotensin-aldosterone system inhibitors and COVID-19.

Wong SY, Brubaker AL, Wang AX, Taiwo AA, Melcher ML. Wong SY, et al. Clin Transplant. 2020 Jul;34(7):e13991. doi: 10.1111/ctr.13991. Epub 2020 Jun 15. Clin Transplant. 2020. PMID: 32446267 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year